TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT02038465

Intervention type: DEVICE
Group type: OTHER
Intervention: Questionary
Description: Test the effectiveness of two techniques of cognitive remediation of autobiographical memory using an innovative tool called SenseCam ® for patient

Intervention type: DEVICE
Group type: OTHER
Intervention: Questionary
Description: Test the effectiveness of two techniques of cognitive remediation of autobiographical memory using an innovative tool called SenseCam ® for patient

Intervention type: DEVICE
Group type: OTHER
Intervention: Questionary
Description: Test the effectiveness of two techniques of cognitive remediation of autobiographical memory using an innovative tool called SenseCam ® for healthy volunteers

Intervention type: DEVICE
Group type: OTHER
Intervention: Questionary
Description: Test the effectiveness of two techniques of cognitive remediation of autobiographical memory using an innovative tool called SenseCam ® for healthy volunteers
Study: NCT02483143

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: NAC
Description: 3 gr NAC was made up to 1000 ml with NS; a 1 ml/3 mgr NAC solution was obtained and 3 ml/kg NAC+NS solution was administered for 1 h before CTPA and a 1 ml/kg per hour NAC+NS solution was administered for a minimum 6 h after CTPA.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: NaHCO3
Description: 132 mEq NaHCO3 was made up to 1000 ml with NS; and 3 ml/kg NaHCO3+NS solution was administered for 1 h before CTPA and 1 ml/kg per hour NaHCO3+NS solution was administered for a minimum of 6 h after CTPA.
Study: NCT04024826

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ELP
Description: This group will perform the Resistance training intervention on the day 18 of the menstrual cycle, which corresponds to the mid of early luteal phase

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LLP
Description: This group will perform the Resistance training intervention on day 21 of the menstrual cycle, which corresponds to the mid of late luteal phase
Study: NCT02148588

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided peripheral nerve block with 2% lidocaine
Description: Patients will have a peripheral nerve blockade with a local anesthetic (lidocaine)~Assessment of spontaneous and evoked pain responses~Completion of NPSI questionnaire~Mapping of the affected limb
Study: NCT02483702

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Irradiated Blood Transfusions
Description: Same as arm description - need to collect extracellular potassium values.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-Irradiated Blood Transfusions
Description: Same as arm description - need to collect extracellular potassium values.
Study: NCT02061579

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Structured Group Exercise
Description: The study intervention is a 6-month exercise program with structured group sessions conducted in a clinical setting. Group sessions include Aerobic Training and Combined Training. Once-Weekly participants will attend one Combined Training session while thrice-weekly participants will attend two Combined Training sessions and one Aerobic Training session per week. Participants in both groups will attend three exercise evaluations during the intervention period. Participants will also use provided logs to track their daily exercise activities outside of group sessions. Physical activity will be assessed by group session attendance, exercise resistance and intensity, and exercise frequency data collected from exercise logs, surveys, and evaluations.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Structured Group Exercise
Description: The study intervention is a 6-month exercise program with structured group sessions conducted in a clinical setting. Group sessions include Aerobic Training and Combined Training. Once-Weekly participants will attend one Combined Training session while thrice-weekly participants will attend two Combined Training sessions and one Aerobic Training session per week. Participants in both groups will attend three exercise evaluations during the intervention period. Participants will also use provided logs to track their daily exercise activities outside of group sessions. Physical activity will be assessed by group session attendance, exercise resistance and intensity, and exercise frequency data collected from exercise logs, surveys, and evaluations.
Study: NCT04070118

Intervention type: PROCEDURE
Intervention: Measure niche thickness with ultrasound
Description: in patients with previous cesarean section who applied to the emergency department with pain and underwent surgery; Measure niche thickness before operation
Study: NCT00810459

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Trilogy Ventilator
Description: Exposure to one hour on the Trilog ventilator

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Exposure of one hour on the Participants prescribed ventilator
Study: NCT02853032

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active repetitive transcranial magnetic stimulation
Description: The MagPro R30 is an advanced, high performance magnetic stimulator designed primarily for non-invasive clinical use. The non-invasive brain stimulation system will be used to deliver active repetitive electromagnetic pulses in this research study's treatment of post-traumatic stress disorder.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: robotic arm
Description: This robotic system is based on a commercially available neurosurgical robot. The robot is mounted on a mobile (i.e. retractable wheels) cart which holds the robot controller and the TMS power supply and pulse-generation computer. The robotic system will be used for TMS coil positioning/targeting.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: robotic arm
Description: This robotic system is based on a commercially available neurosurgical robot. The robot is mounted on a mobile (i.e. retractable wheels) cart which holds the robot controller and the TMS power supply and pulse-generation computer. The robotic system will be used for TMS coil positioning/targeting.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sham repetitive transcranial magnetic stimulation
Description: The MagPro R30 is an advanced, high performance magnetic stimulator designed primarily for non-invasive clinical use. The non-invasive brain stimulation system will be used to deliver placebo repetitive electromagnetic pulses in this research study's treatment of post-traumatic stress disorder.
Study: NCT02483143

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal Saline
Description: 3 ml/kg NS was administered for 1 h before CTPA and 1 ml/kg per hour was administered for a minimum of 6 h after CTPA.
Study: NCT00003093

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: filgrastim

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: sargramostim

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carboplatin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: doxorubicin hydrochloride

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: etoposide

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: conventional surgery
Study: NCT02014025

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Open hepatectomy
Description: We let the 45 patients who are meet the inclusion criteria .Hospital in hepatobiliary surgery A and D district is Group A ,they will accept Open Hepatectomy: tumors are totally resected by conventional laparotomy.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscope hepatectomy
Description: We let the 45 patients who are meet the inclusion criteria .Hospital in hepatobiliary surgery E district is Group B ,they will accept Laparoscopic Hepatectomy: tumors are totally resected through laparoscopic.
Study: NCT00003093

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: neoadjuvant therapy
Study: NCT04941339

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MRG002
Description: Administrated intravenously
Study: NCT02633735

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Appy CDS
Description: See description under arm/group section
Study: NCT03048773

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: shockwave therapy
Description: Intervention with shockwave therapy
Study: NCT03296852

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: SONAS Ultrasound Device
Description: To assess a baseline value, ultrasound will be transmitted following an automated protocol to increase subsequently the output voltage from 5 volts to 50 volts. At each voltage step the received signals will be acquired and stored. Once the maximum output voltage of 50 Volts has been reached an additional 10 ultrasound pulses will be transmitted and the received data acquired. The total duration of this first data acquisition is 20 seconds. Following the IV bolus injection of Lumason™, ultrasound will be transmitted and received signals acquired following the same protocol as before.
Study: NCT03048773

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: PT
Description: Physical therapy 3 times per week for 3 weeks

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PT
Description: Physical therapy 3 times per week for 3 weeks

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: sham shockwave therapy
Study: NCT03296852

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lumason
Description: An IV line will be placed in a cubital or forearm vein. A bolus of 1.0ml of the ultrasound contrast agent (so called 'Microbubbles') Lumason™, internationally known as SonoVue (Bracco Pharmaceuticals, Italy), will be injected into the IV line, followed by a 5.0ml IV bolus injection of saline. Lumason™ has been FDA approved for cardiac applications to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border. In the context of the present study Lumason™ would be used off-label.
Study: NCT00536848

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GR-1 + Lactobacillus reuteri RC-14

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metronidazole
Study: NCT00473109

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dialysis without systemic heparinization
Description: Dialysis without systemic heparinization
Study: NCT03053934

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online video-based counselling
Description: Videoconferencing facilitates communication between individuals (i.e., the counsellor and the client) in different geographical locations enabling them to interact simultaneously with each other on a computer monitor in real time. In other words, both the client and the therapist communicate live using both visual and audio aids simulating in-person therapy albeit from two separate geographical locations.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Traditional in-person counselling
Description: Traditional in-person counselling is often referred to as face-to-face and can be loosely defined as any mental health intervention, whereby the clinician is in the same room with a client. The terms in-person and same room are used less frequently, but it has been argued that these terms are more descriptive (since in videoconferencing, clients are also seen face-to-face on screen). Therefore, the current study uses the term in-person to describe traditional, face-to-face counselling.
Study: NCT02961244

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Prewarming and perioperative warming with Forced Air Warming device and its blankets.
Study: NCT03544658

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dental prophylaxis
Description: Professional dental prophylaxis including dental scaling and dental polishing with prophylactic paste

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Tooth color assessment by the participant
Description: Tooth color assessment using the VITA Classical shade guide. Assessment will be done with normal light conditions and with a light correcting device
Study: NCT00536848

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Metronidazole
Study: NCT02961244

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Forced Air Warming blanket
Study: NCT02828007

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NIV Group
Description: Each patient will be using Non Invasive Ventilation (NIV) and will use it on each possible ventilation mode in a random order with a 10 minutes washout period between modes.
Study: NCT03287245

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idasanutlin
Description: All participants will receive 150 milligrams (mg) idasanutlin orally, once daily for 5 days, every 28 days, until treatment discontinuation or end of study (up to 2 years). Intra-participant dose-escalation to 200 mg daily for 5 days may be permitted after Cycle 3 for those who demonstrate no hematocrit (Hct) control and/or for those with inadequately controlled leukocytosis and/or thrombocytosis in which the investigator judges that better control is important.
Study: NCT03824392

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Efzofitimod 1.0 mg/kg or Placebo
Description: Participants to receive efzofitimod 1.0 mg/kg IV every 4 weeks or placebo matched to efzofitimod every 4 weeks
Study: NCT03683368

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: YpsoPump Orbit soft
Description: Insulin infusion sets will be used for up to 7 days or until failure
Study: NCT03544658

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Tooth color assessment by the investigator
Description: Tooth color assessment using the VITA Classical shade guide and the VITA Toothguide 3D Master. Assessment will be done with normal light conditions and with a light correcting device

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Tooth color assessment with SpectroShade
Description: Tooth color assessment using SpectroShade (dental spectrophotometer). Color will be registered in VITA Classical and VITA Toothguide 3D Master and CIELab parameters
Study: NCT04158115

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Entire Spine Mobilization
Description: 8 sessions of Following: -Entire Spinal Mobilization of all spinal segment from C0 to C1 to L5 to S1 (10 reps × 3 sets), - Moist heat: 10 to 15 minutes, - Soft tissue Mobilization, - Exercises : (Knee to chest, Bridging. Hamstrings Stretching, TA stretching)

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Segmental Mobilization
Description: 8 sessions of following -Segmental Mobilization: All lumbar segment from L1 to L2 to L5 to S1 (10 reps × 3 sets) - Moist heat: (10 to 15 minutes), -Soft tissue Mobilization~- Exercises: (Knee to chest, Bridging. Hamstrings Stretching, TA stretching)
Study: NCT04199910

Intervention type: OTHER
Intervention: There is no intervention, only research blood samples are collected
Description: Research blood samples collected

Intervention type: OTHER
Intervention: There is no intervention, only research blood samples are collected
Description: Research blood samples collected

Intervention type: OTHER
Intervention: There is no intervention, only research blood samples are collected
Description: Research blood samples collected

Intervention type: OTHER
Intervention: There is no intervention, only research blood samples are collected
Description: Research blood samples collected

Intervention type: OTHER
Intervention: There is no intervention, only research blood samples are collected
Description: Research blood samples collected
Study: NCT01337167

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: V419
Description: V419 (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate \[Meningococcal Outer Membrane Protein Complex\], and Hepatitis B \[Recombinant\] Vaccine) 0.5 mL intramuscular injection at 2, 4, and 6 months of age

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: DAPTACEL™
Description: DAPTACEL™ 0.5 mL intramuscular injection at 15 months of age

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: DAPTACEL™
Description: DAPTACEL™ 0.5 mL intramuscular injection at 15 months of age

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PedvaxHIB™
Description: PedvaxHIB™ 0.5 mL intramuscular injection at 15 months of age

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Prevnar 13™
Description: Prevnar 13™ 0.5 mL intramuscular injection at 2, 4, 6, and 15 months of age

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Prevnar 13™
Description: Prevnar 13™ 0.5 mL intramuscular injection at 2, 4, 6, and 15 months of age

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: RotaTeq™
Description: RotaTeq™ 2 mL oral dose at 2, 4, and 6 months of age

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RotaTeq™
Description: RotaTeq™ 2 mL oral dose at 2, 4, and 6 months of age
Study: NCT03824392

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Efzofitimod 1.0 mg/kg or Placebo
Description: Participants to receive efzofitimod 1.0 mg/kg IV every 4 weeks or placebo matched to efzofitimod every 4 weeks

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Efzofitimod 3.0 mg/kg or Placebo
Description: Participants to receive efzofitimod 3.0 mg/kg IV every 4 weeks or placebo matched to efzofitimod every 4 weeks

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Efzofitimod 3.0 mg/kg or Placebo
Description: Participants to receive efzofitimod 3.0 mg/kg IV every 4 weeks or placebo matched to efzofitimod every 4 weeks

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Efzofitimod 5.0 mg/kg or Placebo
Description: Participants to receive efzofitimod 5.0 mg/kg IV every 4 weeks or placebo matched to efzofitimod every 4 weeks
Study: NCT01337167

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: PENTACEL™
Description: PENTACEL™ 0.5 mL intramuscular injection at 2, 4, and 6 months of age
Study: NCT03824392

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Efzofitimod 5.0 mg/kg or Placebo
Description: Participants to receive efzofitimod 5.0 mg/kg IV every 4 weeks or placebo matched to efzofitimod every 4 weeks
Study: NCT03925987

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exposure therapy
Description: 10 weekly sessions of group-based exposure therapy
Study: NCT01282866

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LightSheer Duet
Description: LightSheer Duet HS handpiece
Study: NCT02289469

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PictureRx medication history platform
Description: Tablet PC-based tool to take more complete and accurate medication history
Study: NCT00105664

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Collaborative care model

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Group interventions

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Facilitated consultation
Study: NCT03053778

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Early follow-up
Description: Early follow-up until 4 weeks after discharge
Study: NCT01337167

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Recombivax HB vaccine
Description: Recombivax HB vaccine 0.5 mL intramuscular injection at 2 and 6 months of age

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: ActHIB™
Description: ActHIB™ 0.5 mL intramuscular injection at 15 months of age
Study: NCT02201355

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intensity Modulated Radiotherapy
Description: Patients treated five fractions per week with radiotherapy dose per fraction and cisplatin dose increased according to the treatment table
Study: NCT03010943

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual reality headset
Description: Feasibility and tolerance
Study: NCT02449941

Intervention type: DRUG
Intervention: PPI (proton pump inhibitor)
Description: 1. Pre ESD (endoscopic submucosal dissection)~   * Assessment atrophy and metaplasia in stomach, Check Helicobacter pylori~  * Use of PPI for 2 months~2. Post ESD 1 (After 2 months)~   * Assess the distribution of helicobacter pylori after using PPI.~  * Stop of PPI~3. Post ESD 2 (After 4 months)~   * Assess the distribution of helicobacter pylori after stop of PPI.
Study: NCT01754077

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LENA Linguistic Feedback Reports
Description: LENA feedback reports show hourly/daily estimates for AWC/CTC and TV/electronic media. The feedback reports will include data obtained from LENA home audio recordings that the families complete. Feedback reports are only given to parents for 8 weekly recordings. The parent does not receive a feedback report for the baseline recordings or the follow-up recordings.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home Visiting Educational Session
Description: A research assistant visited the homes of the participants to discuss strategies, skills, and barriers related to enriching children's language environments. The visits included a multi-media educational module, video modeling exercise, goal setting, and linguistic feedback report review. There were 8 weekly home visits in the intervention program.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Childhood Nutrition Education
Description: The childhood nutrition education intervention is a brief home-visiting intervention during which parents receive information on nutrition from a research assistant. The intervention mirrored the experimental group's educational intervention and decreased the likelihood of differences between groups being the result of attentional effects. This intervention is received by the control group.
Study: NCT04457570

Intervention type: OTHER
Intervention: mortality
Description: To measure the excess risk of mortality of patients with a history of cancer among patients hospitalized for a SARS-CoV-2 infection

Intervention type: OTHER
Intervention: mortality
Description: To measure the excess risk of mortality of patients with a history of cancer among patients hospitalized for a SARS-CoV-2 infection